Glycaemic effects of weight loss drug locaserin reduce diabetes risk

Modest weight loss associated with the use of lorcaserin has been shown to improve metabolic health in overweight and obese people with or at high risk for diabetes and adverse cardiovascular events. The findings with the serotonergic agonist are consistent with other evidence such as the DiRECT trial that weight loss can help with remission ...

Already a member?

Login to keep reading.

© 2021 the limbic